Baricitinib Impurity 11 | CAS 1024120-52-2 - Request Quote
Baricitinib Impurity 11
| SZ CAT No: | SZ-B038022 |
| CAS No | 1024120-52-2 |
| Mol.F. | C7H11BrN2O |
| Mol.Wt. | 219.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Baricitinib Impurity 11 is chemically 4-Bromo-1-(1-ethoxyethyl)-1H-pyrazole. Baricitinib Impurity 11 is supplied with detailed characterization data compliant with regulatory guideline. Baricitinib Impurity 11 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Baricitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1024120-52-2
Purchase 1024120-52-2
Order 1024120-52-2
Enquire 1024120-52-2
price of 1024120-52-2
1024120-52-2 Supplier
1024120-52-2 Manufacturer
1024120-52-2 Exporter
buy high quality Baricitinib Impurity 11
Purchase Baricitinib Impurity 11
Baricitinib Impurity 11 suppliers
Baricitinib Impurity 11 manufacturers
Baricitinib Impurity 11 price
Order Baricitinib Impurity 11
Enquire Baricitinib Impurity 11
Baricitinib Impurity 11 cost
Baricitinib Impurity 11 Supplier
Baricitinib Impurity 11 Distributor
Baricitinib Impurity 11 for Method Validation
Baricitinib Reference Standard
Baricitinib Impurity 11 for ANDA Filing
Baricitinib Impurity 11 for Forced Degradation Studies
Baricitinib Impurity 11 Identification Standards
Baricitinib Impurity 11 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


